Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (266)	7/1/1998 3:50:00 PM
From: Dennis	Read Replies (1) \| Respond to of 645

If it was approved, can they deliver this season?? Do they have the capacity?? Thanks ahead

To: Vector1 who wrote (266)	7/1/1998 4:22:00 PM
From: Vector1	Read Replies (1) \| Respond to of 645

Looking back at past articles it appears the company believes its possible to have approval in time for the season. -- ----------- 05/14 5:42P ... Earlier Thursday, the New England Journal of Medicine reported the findings of Aviron's clinical trial of FluMist. Researchers found that the vaccine was highly effective, safe and well-tolerated in more than 1,600 children. "Its reallly the last major milestone before we file the company's application with the U.S. Food and Drug Administration for the product's eventual sale," Read said in an interview with CNBC Thursday. "Perhaps we will have doses available for the 1999 influenza season," he said.